We use cookies for a better user experience. Read our Privacy Policy

I Agree

Mycoplasma Diagnostics Market Trends, 2016-2024

Mycoplasma Diagnostics Market (Products - Kits & Reagents, Instruments, and Software & Services; Technologies - PCR, Immunoassay (ELISA, RIA), DNA Staining, and Microbial Culture Techniques; End Users - Hospitals, Diagnostic Laboratories, and Clinics) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Mycoplasma Diagnostics Market - An Overview

Mycoplasma diagnostics is a group of medical examinations performed to assess nucleic acids or proteins at the molecular level. This form of diagnostics helps in the quick detection of mycoplasma contagions in samples. The mycoplasma diagnostics tests is considered a rapidly-growing segment in the in-vitro diagnostic industry. The mycoplasma diagnostic form of examination provides swift turnaround time, a decrease in sequencing costs, as well as sensitivity

The mycoplasma diagnostics market has expanded in the last few decades since the entry of the Polymerase chain reaction (PCR). At present, the PCR segment is the biggest contributor, in terms of revenue that is generated from the mycoplasma diagnostics market. The PCR demand is expected to rise significantly in the forthcoming years because of an increasing number of hospital-acquired disorders. With greater awareness about the PCR advantages, the demand for mycoplasma diagnostics examinations could rise in future.

The global mycoplasma diagnostics market has been divided into five regions: Latin America, North America, the Asia Pacific, Europe, and the Middle East & Africa. In 2016, North America dominated the mycoplasma diagnostics market with a projected share of 35.4% in the overall market. The presence of many big research laboratories as well as a high level of awareness among the public makes the North American region favourable for the growth of the mycoplasma diagnostics market. It is estimated that there are more than 600 laboratories in the US that conduct mycoplasma diagnostics tests. The mycoplasma diagnostics market is anticipated to benefit from the rising demand for point of care testing.

Asia Pacific is expected to provide profitable opportunities for the growth of the mycoplasma diagnostics market during the forecast period. The region has witnessed increased cases of respiratory tract infection in the last few years and the emerging countries that are a part of the Asia Pacific region have spent heavily on building strong healthcare facilities. These factors have played an important role in the overall growth of the mycoplasma diagnostics market. Furthermore, the Asia Pacific market is anticipated to benefit from the increasing demand for personalized medicines, greater public awareness and an increase in investments for research and development activities.

Global Mycoplasma Diagnostics Market: Snapshot

Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in vitro diagnostic industry.  Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests. But decline in cost per sample analysis and labor cost, improvements in automation and introduction of advanced technologies has extended the usage of molecular diagnostics in wide range of applications. The market for mycoplasma diagnostics has expanded since 1990’s with the introduction of PCR. It is estimated that in the U.S. over 600 laboratories and 200 independent laboratories perform mycoplasma diagnostics test to simplify and accelerate the testing process.

The global mycoplasma diagnostics market, which stood at US$602.0 mn in 2016, is forecast to reach US$1.35 bn by the end of 2024. If these figures hold true, the market will exhibit a CAGR of 10.6% between 2016 and 2024.

mycoplasma diagnostics market

Demand for Software & Services Projected to Increase at High Pace

Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.

By technology, PCR, immunoassay, DNA staining, microbial culture techniques and others are the key market segments. Currently, the PCR segment contributes the largest share in the revenue generated by the market based on technology. The demand for PCR is forecast to increase considerably in the coming years owing to the rising incidence of hospital acquired infections. The diagnostic technology provides rapid turnaround time, reduction in cost of sequencing, and sensitivity. As end users get to know benefits offered by PCR, the demand from the segment will increase in response.

By end users, global mycoplasma diagnostic market is dominated by hospitals & diagnostic laboratories. Hospitals & diagnostic laboratories are an important channel for the usage of multiplexed diagnostic products & offer a range of diagnosis solutions. They are an important channel for the usage of multiplexed diagnostic products. According to the norms of government health care facilities, they offer reimbursement plans and advanced technology systems for treatment.

North America Holds Dominance, But Asia Pacific to Report Higher CAGR

Regionally, North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa constitute the key market segments. Among these regions, North America held dominance in 2016 with an estimated share of 35.4% in the overall market. Several large research laboratories are present in North America. Besides this, the region also boasts a high level of public awareness, which provides an environment conducive to the growth of the mycoplasma diagnostics market. Furthermore, in the coming years, the market is expected to gain from the increasing demand for point of care testing.

Despite dominance exercised by the North America market, during the forecast period Asia Pacific will showcase more lucrative opportunities. Besides the high incidence of respiratory tract infection witnessed in the last few years, the emerging nations in the region boasts high healthcare spending, which has helped the mycoplasma market exhibit strong growth in Asia Pacific. In addition, the regional market is forecast to gain from the rising demand for personalized medicines, rise in research and development investments, and the rising public awareness.

Key players operating in this market include F. Hoffmann-La Roche Ltd., Agilent Technologies, Sartorius Stedim BioOutsource Limited, Savyon Diagnostics, Takara Bio Inc. (Takara Holding Company Inc.), Lonza Group, Merck KGaA, and Charles River Laboratories International, Inc. among others.

The global mycoplasma diagnostics market is segmented as follows:

by Product

  • Kits & Reagents
  • Instruments
  • Software & Services

by Technology

  • PCR
  • Immunoassay
    • ELISA
    • RIA
  • DNA staining
  • Microbial Culture Techniques
  • Others

by End Users

  • Hospitals
  • Diagnostic Laboratories
  • Clinics
  • Others

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of mycoplasma diagnostics market?

The global mycoplasma diagnostics market was worth US$602.0 mn and is projected to reach a value of US$1.35 bn by the end of 2024

What is the anticipated CAGR of the mycoplasma diagnostics market in the forecast period?

Mycoplasma diagnostics market is anticipated to grow at a CAGR of 10.6% during the forecast period

Which region is expected to project the highest market share in the global mycoplasma diagnostics market?

North America accounted for a major share of the global mycoplasma diagnostics market

What are the key driving factors for the growth of the mycoplasma diagnostics market?

The global market for mycoplasma infections diagnostics is driven primarily by the growing prevalence of respiratory tract infections that can lead to incidence of lung cancer, tuberculosis, and obstructive pulmonary diseases

Who are the key players in the global mycoplasma diagnostics market?

Key players in the global mycoplasma diagnostics market include F. Hoffmann-La Roche Ltd., Agilent Technologies, Sartorius Stedim BioOutsource Limited, Savyon Diagnostics, Takara Bio Inc. (Takara Holding Company Inc.), Lonza Group, Merck KGaA, and Charles River Laboratories International, Inc.

1 Preface
    1.1 Report Scope
    1.2 Market Segmentation 
    1.3 Research Highlights

2 Assumptions and Research Methodology
    2.1 Assumptions    
    2.2 Acronyms Used
    2.3 Research Methodology

3 Executive Summary

4 Market Overview
    4.1 Global Mycoplasma Diagnostic Market Snapshot
    4.2 Key Industry Events
    4.3 Market Indicators

5 Market Dynamics
    5.1 Drivers and Restraints Snapshot Analysis
    5.2 Drivers
    5.3 Restraints
    5.4 Opportunity Analysis 
    5.5 Opportunities
    5.6 Porter’s Five Forces Analysis
    5.7 Value Chain Analysis 
    5.8 Global Mycoplasma Diagnostics Market Analysis and Forecast (US$ Mn), 2014–2024
    5.9 Global Mycoplasma Diagnostics Market Market Outlook 
    5.10 Patents & Product Launch Analysis in Diagnostics 
    5.11 Advantages, Disadvantages, & the Availability of Select Mycoplasma Diagnostic Methods
    5.12 Product Distribution Strategies 

6 Global Mycoplasma Diagnostics Market Analysis, by Product Type    
    6.1 Key Findings 
    6.2 Introduction
    6.3 Global Mycoplasma Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2024
    6.4 Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
    6.5 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2015–2024
    6.6 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Instruments, 2015–2024
    6.7 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Software & Services, 2015–2024
    6.8 Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Product Type
    6.9 Key Trends

7 Global Mycoplasma Diagnostics Market Analysis By Technology
    7.1 Key Findings
    7.2 Introduction
    7.3 Global Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
    7.4 Global Mycoplasma Diagnostics Market Value Share Analysis, by Immunoassay, 2016 and 2024
    7.5 Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2024
    7.6 Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology (Immunoassay), 2015–2024
    7.7 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PCR, 2014–2024
    7.8 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay, 2014–2024
    7.9 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DNA Staining, 2014–2024
    7.10 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microbial Culture Technique, 2014–2024
    7.11 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2014–2024
    7.12 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - ELISA, 2014–2024
    7.13 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - RIA, 2014–2024
    7.14 Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology
    7.15 Key Trends

8 Global Mycoplasma Diagnostics Market Analysis, by End-user
    8.1 Key Findings
    8.2 Introduction
    8.3 Global Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
    8.4 Global Mycoplasma Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by End-user, 2014–2024
    8.5 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Hospitals)
    8.6 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Diagnostic Laboratories)
    8.7 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Clinics)
    8.8 Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user
    8.9 Key Trends

9 Global Mycoplasma Diagnostics Market Analysis By Region
    9.1 Global Regulatory Scenario
    9.2 Global Mycoplasma Diagnostics Market Value Share Analysis By Region Type, 2016 and 2024
    9.3 Global Mycoplasma Diagnostics Market Size (US$ Mn)) Forecast, By Region Type, 2014–2024
    9.4 Global Mycoplasma Diagnostics Market Attractiveness Analysis, By Region Type

10 North America Mycoplasma Diagnostics Market Analysis
    10.1 Key Findings
    10.2 North America Mycoplasma Diagnostics Market Overview
    10.3 North America Market Value Share Analysis By Country, 2016 and 2024
    10.4 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
    10.5 North America Market Value Share Analysis By Product Type, 2016 and 2024
    10.6 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
    10.7 North America Market Value Share Analysis By Technology , 2016 and 2024
    10.8 North America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    10.9 North America Market Value Share Analysis By Technology , 2016 and 2024
    10.10 North America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    10.11 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology 
    10.12 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
    10.13 North America Mycoplasma Diagnostics Market Value Share Analysis By End Users , 2016 and 2024
    10.14 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User , 2015–2024
    10.15 North America Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
    10.16 North America Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
    10.17 North America Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

11 Europe Mycoplasma Diagnostics Market Analysis
    11.1 Key Findings
    11.2 Europe Mycoplasma Diagnostics Market Overview
    11.3 Europe Market Value Share Analysis By Country, 2016 and 2024
    11.4 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
    11.5 Europe Market Value Share Analysis By Product Type, 2016 and 2024
    11.6 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
    11.7 Europe Market Value Share Analysis By Technology , 2016 and 2024
    11.8 Europe Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    11.9 Europe Market Value Share Analysis By Technology , 2016 and 2024
    11.10 Europe Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    11.11 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology 
    11.12 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
    11.13 Europe Mycoplasma Diagnostics Market Value Share Analysis By End Users,  2016 and 2024
    11.14 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
    11.15 Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
    11.16 Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
    11.17 Europe Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

12 Asia Pacific  Mycoplasma Diagnostics Market Analysis
    12.1 Key Findings
    12.2 Asia Pacific  Mycoplasma Diagnostics Market Overview
    12.3 Asia Pacific  Market Value Share Analysis By Country, 2016 and 2024
    12.4 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
    12.5 Asia Pacific  Market Value Share Analysis By Product Type, 2016 and 2024
    12.6 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
    12.7 Asia Pacific  Market Value Share Analysis By Technology , 2016 and 2024
    12.8 Asia Pacific  Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    12.9 Asia Pacific  Market Value Share Analysis By Technology , 2016 and 2024
    12.10 Asia Pacific  Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    12.11 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology 
    12.12 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
    12.13 Asia Pacific  Mycoplasma Diagnostics Market Value Share Analysis By End Users , 2016 and 2024
    12.14 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User , 2015–2024
    12.15 Asia Pacific  Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
    12.16 Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
    12.17 Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

13 Latin America Mycoplasma Diagnostics Market Analysis
    13.1 Key Findings
    13.2 Latin America Mycoplasma Diagnostics Market Overview
    13.3 Latin America Market Value Share Analysis By Country, 2016 and 2024
    13.4 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
    13.5 Latin America Market Value Share Analysis By Product Type, 2016 and 2024
    13.6 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
    13.7 Latin America Market Value Share Analysis By Technology , 2016 and 2024
    13.8 Latin America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    13.9 Latin America Market Value Share Analysis By Technology , 2016 and 2024
    13.10 Latin America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
    13.11 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology 
    13.12 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
    13.13 Latin America Mycoplasma Diagnostics Market Value Share Analysis By End Users , 2016 and 2024
    13.14 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User , 2015–2024    
    13.15 Latin America Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
    13.16 Lain America Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
    13.17 Latin America Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

14 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Analysis
    14.1 Key Findings
    14.2 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Overview
    14.3 Middle East & Africa (MEA) Market Value Share Analysis By Country, 2016 and 2024
    14.4 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
    14.5 Middle East & Africa (MEA) Market Value Share Analysis By Product Type, 2016 and 2024
    14.6 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
    14.7 Middle East & Africa (MEA) Market Value Share Analysis By Technology, 2016 and 2024    
    14.8 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
    14.9 Middle East & Africa (MEA) Market Value Share Analysis By Technology, 2016 and 2024
    14.10 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
    14.11 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology 
    14.12 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
    14.13 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Value Share Analysis By End Users, 2016 and 2024
    14.14 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
    14.15 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
    14.16 Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
    14.17 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

15 Competition Landscape
    15.1 Global Mycoplasma Diagnostics Market Share Analysis, by Company, 2016 
    15.2 Competition Matrix

16 Company Profiles
    16.1 Agilent Technologies, Inc 
           16.1.1 Company Overview
           16.1.2 Business Overview
           16.1.3 Financial Overview
           16.1.4 SWOT Analysis
           16.1.5 Strategic Overview
    16.2 Thermo Fisher Scientific Inc 
           16.2.1 Company Overview
           16.2.2 Business Overview
           16.2.3 Financial Overview
           16.2.4 SWOT Analysis
           16.2.5 Strategic Overview
    16.3 PromoCell GmbH 
           16.3.1 Company Overview
           16.3.2 Business Overview
           16.3.3 Financial Overview
           16.3.4 SWOT Analysis
           16.3.5 Strategic Overview
    16.4 Charles River Laboratories International, Inc 
           16.4.1 Company Overview
           16.4.2 Business Overview
           16.4.3 Financial Overview
           16.4.4 SWOT Analysis
           16.4.5 Strategic Overview
    16.5 Merck KGaA 
           16.5.1 Company Overview
           16.5.2 Business Overview
           16.5.3 Financial Overview
           16.5.4 SWOT Analysis
           16.5.5 Strategic Overview
    16.6 Lonza Group 
           16.6.1 Company Overview
           16.6.2 Business Overview
           16.6.3 Financial Overview
           16.6.4 SWOT Analysis
           16.6.5 Strategic Overview
    16.7 Takara Bio Inc (Takara Holding Company Inc.)
           16.7.1 Company Overview
           16.7.2 Business Overview
           16.7.3 Financial Overview
           16.7.4 SWOT Analysis
           16.7.5 Strategic Overview
    16.8 Savyon Diagnostics
           16.8.1 Company Overview
           16.8.2 Business Overview
           16.8.3 Financial Overview
           16.8.4 SWOT Analysis
           16.8.5 Strategic Overview
    16.9 Tecan Trading AG (Tecan Group) 
           16.9.1 Company Overview
           16.9.2 Business Overview
           16.9.3 Financial Overview
           16.9.4 SWOT Analysis
           16.9.5 Strategic Overview
    16.10 Sartorius Stedim BioOutsource Limited 
           16.10.1 Company Overview
           16.10.2 Business Overview
           16.10.3 Financial Overview
           16.10.4 SWOT Analysis
           16.10.5 Strategic Overview
    16.11 American Type Culture Collection (ATCC) 
           16.11.1 Company Overview
           16.11.2 Business Overview
           16.11.3 Financial Overview
           16.11.4 SWOT Analysis
           16.11.5 Strategic Overview
    16.12 F Hoffmann-La Roche Ltd 
           16.12.1 Company Overview
           16.12.2 Business Overview
           16.12.3 Financial Overview
           16.12.4 SWOT Analysis
           16.12.5 Strategic Overview

List of Tables 

Table 01: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 02: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2024
Table 03: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2024
Table 04: Global Mycoplasma Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by End-user, 2015–2024
Table 05: Global Mycoplasma Diagnostics Market Size (US$ Mn)) Forecast, by Region, 2014–2024
Table 06: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 07: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
Table 08: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 09: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 10: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 11: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2014–2024
Table 12: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
Table 13: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
Table 14: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 15: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 16: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 17: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 18: Asia Pacific Market Size (US$ Mn) Forecast, by Technology, 2014–2024
Table 19: Asia Pacific Market Size (US$ Mn) Forecast, by Immunoassay, 2015–2024
Table 20: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2024
Table 21: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, By Country, 2014–2024
Table 22: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
Table 23: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
Table 24: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 25: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2014–2024
Table 26: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2014–2024
Table 27: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2014–2024
Table 28: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
Table 29: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 30: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024

List of Figures 

Figure 1: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2014–2024
Figure 2: Global Mycoplasma Diagnostics Market Value Share, by Product Type (2016)
Figure 3: Global Mycoplasma Diagnostics Market Value Share, by technology (2016) 
Figure 4: Global Mycoplasma Diagnostics Market Value Share, by Region (2016)
Figure 5: Global Mycoplasma Diagnostics Market Value Share, by End-user (2016) 
Figure 06: Global Mycoplasma Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 07: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2015–2024
Figure 08: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Instruments, 2015–2024
Figure 09: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Software & Services, 2015–2024
Figure 10: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Product Type
Figure 11: Global Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
Figure 12: Global Mycoplasma Diagnostics Market Value Share Analysis, by Immunoassay, 2016 and 2024
Figure 13: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PCR, 2014–2024
Figure 14: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay, 2014–2024
Figure 15: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DNA Staining, 2014–2024
Figure 16: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microbial Culture Technique, 2014–2024
Figure 17: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2014–2024
Figure 18: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - ELISA, 2014–2024
Figure 19: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - RIA, 2014–2024
Figure 20: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology
Figure 21: Global Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
Figure 22: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Hospitals)
Figure 23: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Diagnostic Laboratories)
Figure 24: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Clinics)
Figure 25: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (By Others)
Figure 26: Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user
Figure 27: Global Mycoplasma Diagnostics Market Value Share Analysis, by Region, 2016 and 2024
Figure 28: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Region
Figure 29: North America Market Size (US$ Mn) Forecast, 2015–2024
Figure 30: North America Market Size Y-o-Y Growth Projections, 2015–2024
Figure 31: North America Market Value Share Analysis By Country, 2016 and 2024
Figure 32: North America Market Value Share Analysis By Product Type, 2016 and 2024
Figure 33: North America Market Value Share Analysis By Technology, 2016 and 2024
Figure 34: North America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
Figure 35: North America Mycoplasma Diagnostics Market Value Share Analysis By End Users, 2016 and 2024
Figure 36: North America Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type 
Figure 37: North America Market Attractiveness Analysis By Technology
Figure 38: North America Market Attractiveness Analysis By End Users
Figure 39: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 40: Europe Mycoplasma Diagnostics Market attractiveness by country.
Figure 41: Europe Market Value Share Analysis By Country, 2016 and 2024
Figure 42: Europe Market Value Share Analysis By Product Type, 2016 and 2024
Figure 43: Europe Market Value Share Analysis By Technology, 2016 and 2024
Figure 44: Europe Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
Figure 45: Europe Market Value Share Analysis By End Users, 2016 and 2024
Figure 46: Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type 
Figure 47: Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
Figure 48: Europe Mycoplasma Diagnostics Market Attractiveness Analysis By End Users
Figure 49: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 50: Asia Pacific Market Attractiveness Analysis By Country
Figure 51: Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
Figure 52: Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 53: Asia Pacific Market Value Share Analysis, by Technology, 2016 and 2024
Figure 54: Asia Pacific Mycoplasma Diagnostics Market Value Share Analysis, by Immunoassay, 2016 and 2024
Figure 55: Asia Pacific Market Value Share Analysis, by End-user, 2016 and 2024
Figure 56: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Product Type
Figure 57: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology
Figure 58: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user
Figure 59: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 60: Latin America Market attractiveness by country, 2015–2024
Figure 61: Latin America Market Value Share Analysis By Country, 2016 and 2024
Figure 62: Latin America Market Value Share Analysis By Product Type, 2016 and 2024
Figure 63: Latin America Market Value Share Analysis By Technology, 2016 and 2024
Figure 64: Latin America Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
Figure 65: Latin America Market Value Share Analysis By End Users, 2016 and 2024
Figure 66: Latin America Market Attractiveness Analysis By Product Type 
Figure 67: Latin America Market Attractiveness Analysis By Technology
Figure 68: Latin America Market Attractiveness Analysis By End Users
Figure 69: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 70: Middle East & Africa Mycoplasma Diagnostics Market Size Y-o-Y Growth Projections, 2015–2024
Figure 71: Middle East & Africa Market Value Share Analysis By Country, 2016 and 2024
Figure 72: Middle East & Africa Market Value Share Analysis By Product Type, 2016 and 2024
Figure 73: Middle East & Africa Market Value Share Analysis, by Technology, 2016 and 2024
Figure 74: Middle East & Africa Market Value Share Analysis, by Immunoassay, 2016 and 2024
Figure 75: Middle East & Africa Mycoplasma Diagnostics Market Value Share Analysis By End Users, 2016 and 2024
Figure 76: Middle East & Africa Market Attractiveness Analysis By Product Type 
Figure 77: Middle East & Africa Market Attractiveness Analysis By Technology
Figure 78: Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis By End Users
Figure 79: Global Market Share Analysis, by Company, 2016 (Estimated)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

542

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved